Endovascular Embolization for Pelvic Congestion Syndrome in Women
Official title: Role of Endovascular Management of Pelvic Congestion Syndome
Run by Sohag University · NCT07735156 · Data updated 2026-11-12
This study tests whether endovascular embolization can relieve chronic pelvic pain and improve quality of life for women with pelvic congestion syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 17 Years to 55 Years |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag, Sohag Governorate) |
| Status | Recruiting |
| Started | January 14, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | June 20, 2027 |
| Registry record updated | July 29, 2026 |
| Trial ID | NCT07735156 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with chronic pelvic pain for at least 6 months and imaging-confirmed PCS who are willing to undergo embolization.
✕Probably not a fit
Patients with alternative causes of pelvic pain, contraindications to iodinated contrast, or conditions that preclude embolization may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective interventional study will enroll women with clinically suspected and imaging-confirmed pelvic congestion syndrome to receive endovascular embolization. Participants will undergo standard evaluation, treatment, and follow-up to assess safety, technical success, and symptom relief. Outcomes will include pain scores, overall symptom improvement, and any procedure-related complications. Data will be collected according to institutional protocols to characterize effectiveness in real-world clinical settings.
Why it matters
Potential benefit: If successful, embolization could reduce pain and improve daily function for women with PCS.
How similar studies have gone: Endovascular embolization has shown promising results in prior studies, but prospective data in this specific setting remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patients aged 18 years or older. * Chronic pelvic pain for more than 6 months. * Clinical suspicion of pelvic congestion syndrome. * Imaging findings consistent with pelvic congestion syndrome on Doppler ultrasound, CT venography, MR venography, or catheter venography. * Patients willing to undergo endovascular embolization. * Written informed consent obtained Exclusion Criteria: * Pregnancy. * Active pelvic inflammatory disease. * Known pelvic malignancy. * Chronic pelvic pain due to other identifiable causes (e.g., endometriosis, large uterine fibroids). * Contraindication to iodinated contrast media. * Severe renal impairment. * Uncorrectable coagulation disorders. * Refusal to participate.
Where it's running
-
Interventional radiology unit, Sohag university hospital
Sohag, Sohag Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Mohammed Zaki Ali, Professor of Radiology — Sohag University
- Study coordinator: Ahmed Nageh Younis, M.B.B.Ch.
- Email: Ahmed.Nageh@med.sohag.edu.eg
- Phone: 00201009800845
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing glue embolization and conservative treatment for pelvic congestion syndrome
This study is testing whether a new glue treatment works better than standard care for women aged 30 to 50 with pelvic congestion syndrome to help relieve their chronic pelvic pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.